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ABSTRACT
A major challenge in the study of mycobacterial RNA
biology is the lack of a comprehensive RNA isola-
tion method that overcomes the unusual cell wall
to faithfully yield the full spectrum of non-coding
RNA (ncRNA) species. Here, we describe a simple
and robust procedure optimized for the isolation of
total ncRNA, including 5S, 16S and 23S ribosomal
RNA (rRNA) and tRNA, from mycobacteria, using
Mycobacterium bovis BCG to illustrate the method.
Based on a combination of mechanical disruption
and liquid and solid-phase technologies, the method
produces all major species of ncRNA in high yield
and with high integrity, enabling direct chemical and
sequence analysis of the ncRNA species. The re-
producibility of the method with BCG was evident
in bioanalyzer electrophoretic analysis of isolated
RNA, which revealed quantitatively significant differ-
ences in the ncRNA profiles of exponentially growing
and non-replicating hypoxic bacilli. The method also
overcame an historical inconsistency in 5S rRNA
isolation, with direct sequencing revealing a novel
post-transcriptional processing of 5S rRNA to its
functional form and with chemical analysis revealing
seven post-transcriptional ribonucleoside modifica-
tions in the 5S rRNA. This optimized RNA isolation
procedure thus provides a means to more rigorously
explore the biology of ncRNA species in mycobacte-
ria.
INTRODUCTION
InfectionwithMycobacterium tuberculosis (Mtb) represents
one of the most widespread microbial diseases, with nearly
one-third of the world’s population showing signs of expo-
sure, more than 20 million people actively infected and al-
most 80% of the population of some countries testing pos-
itive in tuberculin tests (1,2). This rate of infection is due
to both a paucity of diagnostic tools (3–6) and ineffective
chemotherapy in the face of emerging drug-resistance (7,8),
both of which reflect poor understanding of mycobacterial
biology and host–pathogen interactions (9,10). One feature
of mycobacterial biology that has hampered investigations
is a thick, waxy cell wall consisting of a network of pep-
tidoglycans, arabinogalactans, mycolic acids and polysac-
charides (11,12), which makes mycobacteria resistant to ly-
sis by most commercial chaotropic or cell lysis reagents
and poses challenges to the rigorous purification of cellu-
lar biomolecules. We are concerned here with the isolation
of non-coding RNA (ncRNA). The importance of rigor-
ous ncRNA purification is illustrated by recent advances in
RNA sequencing and bioinformatics that have led to the
discovery of disease-relevant ncRNA species in mycobac-
teria (13,14), while critical features of modified ribonu-
cleosides in transfer RNA (tRNA) and ribosomal RNA
(rRNA) are known to play a role in adaptive responses
to stress (15–18). In all cases, the systems-level analysis of
ncRNA requires unbiased isolation of RNA with sequence
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integrity and relative quantity intact. Numerous methods
for mycobacterial RNA isolation have been developed that
include liquid or solid-phase extraction following cell lysis
by either sonication, enzymatic hydrolysis, chemical treat-
ment, French pressure cell rupture or bead-beating (19–22).
However, there has been no rigorous optimization of my-
cobacterial RNA isolation techniques to ensure purification
of the full spectrumof ncRNA species with quantitative and
qualitative fidelity. Furthermore, in addition to recognized
size- and sequence-dependent biases in the isolation of spe-
cific ncRNA species (23), these methods require large quan-
tities of cells or have time-consuming steps that can lead to
degradation or enzymatic modification of the RNA (24). To
address these problems, we developed an optimized method
for efficient isolation of all types of ncRNA from mycobac-
teria with high biological fidelity. UsingMycobacterium bo-
vis Bacille Calmette-Gue´rin (BCG) as the model mycobac-
terial species, themethod represents a combination of bead-
beating with phenol-chloroform and solid-phase extraction
steps optimized for both yield and quality of tRNA, 5S, 16S
and 23S rRNA, as well as mRNA for seven genes. Applica-
tion of the method to BCG revealed hypoxia-induced al-
terations of the relative quantities of 16S and 23S rRNA, a
novel post-transcriptional processing of 5S rRNA, and the
first complete analysis of the full set of modified ribonucle-
osides in mycobacterial 5S rRNA.
MATERIALS AND METHODS
Bacterial cultures
For exponentially growing mycobacteria, M. bovis BCG
(str. Pasteur 1173P2; BCG) was grown at 37◦C in a shaking
incubator in Middlebrook 7H9 broth (Difco, BD Diagnos-
tics, Sparks, MD, USA) to an OD600 of 0.6–0.8. BCG cells
in a hypoxia-induced non-replicative state were obtained us-
ing the Wayne model adapted from Low et al. (25). Briefly,
a culture of exponentially growing BCG in Dubos broth
(Difco) was diluted to an OD600 of 0.05 and placed in a
tightly sealed (latex-lined cap) 1-l glass flask (Duran,Mainz,
Germany) with stirring at 170 rpm and air headspace vol-
ume of 450 ml. With a plateau in cell growth at 7 days (as
determined by OD600), induction of a non-replicative state
was confirmed by the absence of change in OD600 for the
next 14 days, at which point the cells were harvested (Sup-
plementary Figure S1).
Development of the RNA isolation method
The optimized RNA isolation protocol was developed
around a simple framework consisting of lysis by bead-
beating in a denaturing extraction solvent, with subsequent
RNA retrieval from the solvent. Using this framework, we
systematically tested a variety of conditions and parame-
ters, including extraction reagent, bead beating conditions
and RNA retrieval method, to define an optimal protocol
to extract all types of ncRNA from BCG. Two nucleic acid
extraction reagents were considered: TRIzol (Invitrogen,
Carlsbad, CA, USA) and phenol:chloroform:isoamyl alco-
hol (Qiagen, Hilden, Germany). While harshly denaturing,
these reagents are insufficient to lyse mycobacterial cells. To
assist in lysing cells, mechanical disruption by bead beat-
ing on a reciprocal shaker was chosen, with optimization
of bead size, extraction solvent volumes and duration. For
retrieval of RNA from the extraction solvent following me-
chanical disruption, we compared simple isopropanol pre-
cipitation of RNA to solid-phase isolation of RNA using
the Purelink miRNA Isolation Kit (Invitrogen, Carlsbad,
CA, USA). A summary of all conditions tested and their
respective nucleic acid yields before DNase I treatment as
assessed by UV spectroscopy is detailed in Supplementary
Table S1; the analyses were performed in three biological
replicates.
Supplementary Figure S2 illustrates the final optimized
ncRNA isolation method, which was applied to BCG cul-
tures growing exponentially or in a hypoxia-induced non-
replicative state. Cells are harvested from culture medium
by centrifugation at 4000 x g for 5 min at 4◦C. Pellets
containing 109 cells were washed in phosphate-buffered
saline (PBS) containing 0.5% Tween 80 to remove media
debris that could interfere with RNA isolation and resus-
pended in 1 ml of ice-cold phenol:chloroform:isoamyl al-
cohol (volume ratio 25:24:1; saturated with 10-mM Tris, 1
mM EDTA, pH 8) and 400 l of 2-M sodium acetate (pH
5.2). The suspension was combined with 100 l of 0.1-mm
zirconia-silica beads (Biospec, Bartlesville, OK, USA) in a
2-ml screw-capped tube and vigorously shaken on a Qia-
gen Tissuelyser II (Qiagen, Hilden, Germany) with cham-
bers pre-chilled to −20◦C to account for heating to ambi-
ent temperature by the end of the 30-min run at a frequency
of 30 Hz. After centrifugation (12 000 x g, 15 min, 4◦C), the
aqueous phase (∼400 l) was transferred into a new tube to
which 215 l of 100% ethanol was added with mixing and
the solution loaded onto a Purelink miRNA Isolation Kit
(Invitrogen, Carlsbad, CA, USA) column (column #1) to
retain large RNA species. Following centrifugation of the
column (12 000 x g, 1 min), the flow-through containing
small RNAs was collected, placed on ice, combined with
700 l of 100% ethanol and loaded onto a second Purelink
miRNA Isolation column (column #2) to retain the small
RNA species. The column was again centrifuged (12 000
x g, 1 min) and the flow-through discarded. Both columns
(#1 and #2) were washed twice with washing buffer pro-
vided with the kit. RNase-free water (50 l) was added to
the columns, which were incubated at ambient temperature
for 2 min followed by centrifugation (12 000 x g, 1 min).
The eluates from columns#1 and#2 containedmainly large
and small RNA, respectively, and these were combined to
recreate a total RNA preparation. Aliquots of each RNA
sample were adjusted to a concentration of 1 ng/l and
thee integrity and relative quantities of the RNA species
in the sample were assessed using an Agilent 2100 Bioan-
alyzer (Agilent Technologies, Santa Clara, CA, USA). Col-
umn eluates were stored at −80◦C.
HPLC purification of individual ncRNA species
Individual RNA species were purified by size-exclusion
(SEC) high-performance liquid chromatography (HPLC),
as described in a recent publication (26). Following addi-
tion of 30 units of DNAse I (Qiagen, Hilden, Germany) to
each sample, the total RNA preparation in 20 l was in-
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jected onto an Agilent Bio SEC3 column (300 A˚, 7.8 × 100
mm; Agilent, Foster City, CA, USA) attached to an Agilent
1200 HPLC system to resolve tRNA and 5S rRNA species.
For 16S and 23S rRNA, anAgilent Bio SEC5 column (1000
A˚, 7.8× 100 mm) was used. Both columns were eluted with
an isocratic gradient with 100-mM ammonium acetate (pH
7.5) at 0.5 ml/min and 60◦C with RNA elution monitored
by UV absorbance. Peak resolution (R) was calculated us-
ing the following equation where tRA and tRB are the re-
tention times for peaks A and B, respectively, and WA and
WB are the peak base widths for peaks A and B, respec-
tively:
R= 2
(
tRB − tRA
WA + WB
)
.
Fractions containing individual RNA species were ana-
lyzed on an Agilent 2100 Bioanalyzer. The 5S rRNA frac-
tion was concentrated and desalted using a 2000-Da molec-
ular weight cut-off spin filter (Sartorius-Stedim, Goettin-
gen, Germany). Purified 5S rRNA was quantified by inte-
grating the UV absorbance for the 5S rRNA peak in HPLC
profiles and interpolating concentration from linear stan-
dard curves prepared with purified 28S rRNA (CCRF-SB
cells), as shown in Supplementary Figure S3.
Sequencing of BCG 5S rRNA
To confirm the identity of the purified 5S rRNA, the 3′ end
of 25 pmol of the RNA was ligated to 50 pmol of a pre-
adenylated DNA adaptor (IDT, Coralville, IA, USA) us-
ing 1.5 g of RNA ligase 2 (truncated K227Q, NEB, Bev-
erly, MA, USA) with incubation at 22◦C for 16 h. The lig-
ated product was purified by SEC3 HPLC and then reverse
transcribed with 200 U of Superscript III RT (Invitrogen,
Carlsbad, CA,USA). The resulting cDNAwas ligated to 50
pmol of another pre-adenylated 3′ adaptor (IDT, Coralville,
IA, USA) using 10 U of T4 RNA ligase 1 (NEB, Bev-
erly, MA, USA) with incubation at 4◦C for 16 h. Following
SEC3 HPLC purification, the ligated cDNA was PCR am-
plified, TA cloned (Genewiz, South Plainfield, NJ, USA),
and sequenced to confirm its identity (Genewiz, South
Plainfield, NJ, USA). Sequence analysis was performed
with Nucleotide BLAST (NCBI) against the annotated full
genome sequence of the same BCG strain (NC 008769.1).
The cDNA sequence from mature 5S rRNA is available on
GenBank (Accession number KC203333).
Analysis of mRNA by quantitative real-time polymerase
chain reaction
To compare the mRNA yield from the optimized RNA iso-
lation approach to that of the conventional TRIzol method,
RNA was isolated from exponentially growing BCG cul-
tures using TRIzol or the optimized RNA isolation method
and DNA was removed using the TURBO DNA-free Kit
(Ambion, Life Technologies, Carlsbad, CA, USA). RNA
(50 ng/l) was reverse transcribed using the iScript cDNA
synthesis kit (Bio-Rad, Hercules, CA, USA) according to
the manufacturer’s instructions. The reverse transcription
program was run as follows: 25◦C for 5 min, 42◦C for 30
min and 85◦C for 5 min, followed by a cooling step at 4◦C.
Two-step real-time quantitative polymerase chain reaction
(qPCR)was then performed using the SsoAdvanced univer-
sal SYBR Green supermix (Bio-Rad, Hercules, CA, USA).
Primer sequences and melting temperatures can be found
in Supplementary Table S3. The qPCR program was run as
follows: 95◦C for 30 s followed by 40 cycles of denaturation
at 95◦C for 15 s and annealing/extension at 60◦C for 30 s. A
melting curve analysis consisting of 0.5◦C increments from
65 to 95◦C was performed for all reactions to ascertain the
specificity of the primers.
Identification and characterization of modified ribonucleo-
sides in BCG 5S rRNA
The full spectrum of modified ribonucleosides in the pu-
rified 5S rRNA was characterized by analysis of ribonu-
cleoside hydrolysates of the RNA by chromatography-
coupled quadrupole time-of-flight and triple quadrupole
mass spectrometry, using methods described previously
(15,26,27). Briefly, purified BCG 5S rRNA was enzymati-
cally hydrolyzed in the presence of antioxidants and deam-
inase inhibitors and the ribonucleosides resolved by HPLC
using a Hypersil GOLD aQ Analytical HPLC Column
(100 × 2.1 mm, 1.9-m particle size) (Thermo Scientific,
Wilmington, DE, USA) coupled to either an Agilent 6460
triple quadrupole mass spectrometer or an Agilent 6520
quadrupole time-of-flight mass spectrometer (LC-MS/MS)
with ESI ionization operated in positive ion mode. The
identity of individual ribonucleosides was confirmed by
comparison with synthetic standards for HPLC retention
time, exact molecular weight and collision-induced dissoci-
ation (CID) fragmentation patterns. In cases where a stan-
dard was not available, a putative structure was inferred
from exact molecular weight and CID fragmentation pat-
terns.
Statistical analysis
Statistical analysis for comparison of qPCR CT values for
the RNA isolation methods and quantities of RNA species
in exponentially growing and hypoxic, non-replicative
(Wayne day 21) cultures was performed using Student’s t-
test with significance set at P ≤ 0.05.
RESULTS
Given the challenges of working with mycobacteria, we
sought to develop a method for purification of ncRNA that
optimized the cell lysis, RNA extraction and RNA purifica-
tion steps to yield the full spectrum of intact ncRNA species
in quantities that reflect their abundances in vivo. The work-
flow shown in Supplementary Figure S2 represents the cul-
mination of a series of optimization studies in which differ-
ent procedures were assessed for the yield of RNA, the rela-
tive quantities of the various ncRNA species and the quality
of the RNA in terms of degradation. Subsequent analysis
of the isolated ncRNA species from BCG revealed several
novel features of RNA biology in mycobacteria.
Optimization of RNA isolation parameters
With all of the optimization data shown in Supplemen-
tary Table S1, optimization of the ncRNA isolation method
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was initiated with a comparison of two standard extrac-
tion reagents, TRIzol and the 25:25:1 mixture of phenol,
chloroform and isoamyl alcohol. An extraction reagent was
added to the cells prior to bead beating to quench adventi-
tious enzymatic reactions during cell lysis, including nucle-
ases and RNA modification enzymes. Given the evidence
for biased isolation of miRNA with TRIzol (23), we com-
pared the yields of the major ncRNA species in BCG with
TRIzol and phenol:chloroform:isoamyl alcohol. A 77% in-
crease in nucleic acid recovery was obtained with phe-
nol:chloroform:isoamyl alcohol compared to TRIzol (Sup-
plementary Table S1). Since phenol:chloroform:isoamyl al-
cohol saturated with 10-mM Tris, pH 8.0, also extracts
DNA, it is possible that part of the observed increase in
nucleic acid mass results from DNA contamination. How-
ever, the yield of longer RNA species, in particular 16S and
23S rRNA, was significantly reduced using traditional acid
phenol or TRIzol-based RNA extraction methods (Supple-
mentary Figure S4). Hence, it was preferable to use the phe-
nol:chloroform:isoamyl alcohol approach to obtain all cel-
lularRNAspecies in high yield and in proportions that truly
reflect their abundances in vivo, with contaminating DNA
subsequently removed by DNAse I digestion or HPLC pu-
rification, without sacrificing longer RNA species (Supple-
mentary Figure S5).
Next, we optimized for cell lysis, comparing the RNA
yield obtained using 0.5- and 1.0-mm glass beads and 0.1-
mm zirconia-silica beads. While 0.5-mm glass beads offered
a 61% increase in nucleic acid yield against 1.0-mm glass
beads, we observed an additional 37% increase in RNA
yield with 0.1-mm zirconia-silica beads (Supplementary Ta-
ble S1). Using 0.1-mm zirconia-silica beads, we optimized
for the duration of bead beating. A duration of 10 min was
sufficient for lysis of mycobacterial cells using the TissueL-
yser II, while a duration of 30 min was required for the Tis-
sueLyser LT. Use of a French press was ruled out due to the
time required for the lysis process (>15 min) in the absence
of denaturants, which allows enzymatic reactions to affect
the spectrum of tRNA and rRNA modifications or cause
RNA degradation.
Finally, to recover RNA from the extraction sol-
vents, we chose the Purelink miRNA Isolation Kit sys-
tem over isopropanol-based RNA precipitation. While
the Purelink columns were optimized for use with TRI-
zol, we modified the manufacturer’s protocol to use phe-
nol:chloroform:isoamyl alcohol instead, which allowed for
the maximal recovery of both large and small RNA. Using
35% ethanol, larger RNA species were recovered on column
#1while smaller RNA species were recovered on column#2
using 70% ethanol.
Qualitative assessment of the optimized ncRNA isolation
method
To assess the performance of the optimized RNA isola-
tion method and the quality of the isolated ncRNA, the
method was applied to BCG cells growing exponentially
and to cells arrested in a hypoxia-induced non-replicative
state that mimics the granuloma of pulmonary mycobac-
terial infections. The quality and relative quantities of the
various ncRNA species in total RNA extracted from BCG
Figure 1. Representative Bioanalyzer electropherograms for BCG RNA
recovered from Purelink miRNA Isolation columns #1 and #2. Electro-
pherograms from column #1 RNA resolved on (A) a Pico Chip and (B) a
Small RNA Chip, and from column #2 RNA resolved on (C) a Pico Chip
and (D) a Small RNA Chip. Electropherograms for the combined RNA
from columns #1 and #2 resolved on (E) a Pico Chip and (F) a Small
RNA Chip. RNA isolated from BCG subjected to hypoxic stress (com-
bined columns #1 and #2) was resolved on (G) a Pico Chip and (H) a
Small RNA Chip. The electropherogram profiles presented here are rep-
resentative of three independent experiments. Note that the small RNA
chip on the Agilent Bioanalyzer 2100 system is not optimized to read large
RNA species (>150 nucleotides). Thus the amount of RNA in the ‘large
RNA’ peak cannot be accurately quantified.
were assessed using a Bioanalyzer with either the Agilent
Pico Chip for large RNA (16S, 23S) and the Agilent Small
RNAChip for small RNA species (<200 nt; miRNA-sized,
tRNA, 5S rRNA). As shown in Figure 1, the peaks corre-
sponding to individual ncRNA species were sharp and dis-
tinguishable. From the exponentially growing cultures, the
eluate from column #1 contained 23S rRNA, 16S rRNA,
5S rRNA and tRNA (Figure 1A and B), whereas column
#2 eluate contained predominantly tRNA (Figure 1C and
D). As a numeric index of the quality of the isolated RNA,
the RNA integrity number (RIN) determined from the Bio-
analyzer profile ranges from 10 for theoretically intact RNA
to 1 for completely degraded RNA (28). For exponentially
growing BCG, the RIN for RNA eluted from column #1 in
four independent extractions was 9.0 ± 0.5, while the RIN
for the combined eluates from columns #1 and #2 from five
independent extractions was 8.5± 0.3. Interestingly, Bioan-
alyzer RNA profiles of the hypoxic cultures displayed lower
relative intensities of the 16S and 23S rRNA peaks com-
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pared to those from exponentially growing cultures (Fig-
ure 1G), with comparable quantities of tRNA under both
conditions (Figure 1H). The RIN for the combined eluates
from columns #1 and #2 from four independent RNA ex-
tractions of hypoxic bacilli was 5.9 ± 0.2, which suggested
a degree of degradation of both 23S and 16S rRNA peaks
(Figure 1G).
To assess the performance of the Purelink miRNA Isola-
tion columns, the proportions of ncRNA species in column
eluates were calculated by manual integration of electro-
pherogram peaks with Bioanalyzer 2100 Expert software. A
comparison of the TRIzol and phenol:chloroform:isoamyl
alcohol methods is summarized in Supplementary Table S2.
Using this approach, large ncRNAs (16S and 23S, identi-
fied by size) were almost entirely recovered from column
#1 along with a significant portion of the small ncRNAs
(<200 nt), while small ncRNAs represented >95% of the
RNA eluted from column #2. The small ncRNAs, whose
identities were assigned based on size, consisted of threema-
jor species: miRNA-like species, tRNA and 5S rRNA. This
retention of small ncRNAs on column #1 points to poten-
tial bias in the small ncRNAs recovered from column #2 as
‘small RNA’. However, by combining the eluates from both
columns, the yield of all ncRNA species was maximized
(Figure 1E and F), with small RNA, and mainly tRNA, as
the dominant species of ncRNA in BCG (Supplementary
Table S2A). For TRIzol however, small RNA was the pre-
dominant species of ncRNA,with tRNAconsisting ofmore
than 80% of the small RNA species (Supplementary Table
S2B).
Considering both the RIN and the recovery
of all ncRNAs from the columns using the phe-
nol:chloroform:isoamyl alcohol approach, the results
with exponentially growing BCG RNA suggest that the
degradation apparent in hypoxic, non-replicative BCG
is not the result of the RNA isolation procedure and
instead reflects physiological processing of the RNA. These
differences were next assessed more quantitatively.
Application of the mycobacterial RNA isolation method in
isolating mRNA
While optimized for the isolation of ncRNA, we investi-
gated the possibility of utilizing our approach for mRNA
isolation. Here, we performed qPCR against seven gene
transcripts on samples derived from RNA isolation with
our approach and samples derived from the conventional
TRIzol RNA isolation approach. Analysis revealed that
there were no significant differences inCT values against five
gene transcripts as illustrated in Table 1. The remaining two
transcripts showed that our RNA isolation method yielded
a lowerCT value (i.e. higher concentration of mRNA) com-
pared to the TRIzol approach.
Application of the mycobacterial RNA isolation method:
quantitative comparison of ncRNA species in non-replicative
and exponentially growing BCG
Given the differences in the relative quantities of 23S and
16S rRNAs between exponential and non-replicative cul-
tures noted in the Bioanalyzer electropherograms (Figure
1E andG), we undertook amore rigorous quantitative anal-
ysis by HPLC resolution of total RNA extracts from BCG
during large-scale purification of ncRNA species. As shown
in Figure 2A and B, we were able to achieve baseline reso-
lution (R = 3.9 ± 0.02) of 16S and 23S rRNAs using an
Agilent size-exclusion HPLC column (SEC5 1000 A˚), while
tRNA and 5S rRNAwere well resolved (R= 4.1± 0.04) us-
ing a solid phase with a smaller pore size (SEC3 300A˚). The
absolute quantities of individual ncRNA species were cal-
culated by interpolating the UV absorbance peak areas for
HPLC-resolved ncRNA species with a standard curve pre-
pared from purified 28S rRNA. These quantities were then
combined with cell counts from colony forming assays for
cultures used in the RNA isolation to calculate the quan-
tity of each rRNA species on a per cell basis. As shown in
Figure 2C, the quantities of 16S and 23S rRNA from ex-
ponentially growing BCG were significantly higher than in
hypoxia-induced non-replicative BCG (P ≤ 0.05), yet there
was no difference in the quantities of 5S rRNA and tRNA
for the two growth conditions. These data for cellular quan-
tities of ncRNA are consistent with theoretical estimates of
mycobacterial molecular composition (29).
Sequence of BCG 5S rRNA
Using the optimized RNA isolation method with BCG, we
were able to reproducibly detect an RNA species with a
size consistent with 5S rRNA. Though relatively abundant
when compared to other bacterial small RNAs, the obser-
vation of 5S rRNA is notable in light of the fact that this
species has never been isolated for direct sequencing. In
other studies of mycobacterial ncRNA, small RNAs were
identified by genomic analysis, by microarray detection of
non-coding transcripts, by shotgun cloning of small RNAs
or by co-purification with RNA-binding proteins (30–34).
Here, pure 5S rRNA-containing fractions were collected
from the HPLC resolution and the 5S rRNA subjected to
sequencing to confirm its identity and to define the sequence
of its mature, functional form. Analysis revealed a sequence
of 109 nt that, in a Blast search, yielded an expect value (E)
of 4 x e−49 and a maximal identity of 100% for severalMy-
cobacterium species, including BCG, M. tuberculosis, My-
cobacterium canettii, andMycobacterium africanum. Com-
parison of the annotated BCG 5S rRNA sequence (M. bo-
vis BCG str. Pasteur 1173P2, Gene ID: 4698678) and the
cDNA sequence of our purified 5S rRNA revealed several
differences in the 3′- and 5′-ends, as shown in Figure 3B.
The purified 5S rRNA lacked 6 nt: positions 1 to 5 and posi-
tion 115 in the annotated 5S rRNA sequence. These results
suggest discrete processing of 5S rRNA from its genomic
transcript as a 9S precursor to the functional sequence by
a mycobacterial enzyme such as RNase E/G (MycRne), as
illustrated in Figure 3C.
The spectrum of modified ribonucleosides in BCG 5S rRNA
To take advantage of the ability to isolate 5S rRNA using
the optimized method, we further explored 5S rRNA mat-
uration by analyzing post-transcriptional modifications.
Here, we used a highly sensitive chromatography-coupled
mass spectrometric platform to identify modified ribonu-
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Figure 2. Size-exclusion HPLC chromatograms for individual RNA species. BCG total RNA was resolved on an Agilent Bio Size Exclusion Column
SEC5, 1000 A˚ (A), or on an Agilent Bio Size Exclusion Column SEC3, 300 A˚ (B). Panels (A) and (B) are representative of six independent HPLC runs.
(C) Cellular quantities of 5S, 16S and 23S rRNA and tRNA species based on HPLC UV absorbance interpolated from a standard curve based on purified
human 28S rRNa. An asterisk indicates a significant difference in the quantity of RNA from exponentially growing cells compared to hypoxic cells on day
21 (unpaired T-test, P ≤ 0.05). Data represent mean ± SD for three biological replicates.
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Table 1. CT values obtained from qPCR analysis of samples derived from TRIzol and the optimized RNA isolation approach
Average CT value
Gene P:C:IAA (optimized approach) TRIzol P-valuea
hspX 21.38 ± 0.20 23.60 ± 0.91 0.014
ethA 27.34 ± 0.11 27.74 ± 1.13 0.608
fdxA 20.62 ± 0.31 20.45 ± 0.56 0.663
relA 23.82 ± 0.33 25.08 ± 0.89 0.081
sigA 24.92 ± 0.15 24.70 ± 0.52 0.093
dosR 23.73 ± 0.36 25.13 ± 0.82 0.053
dosS 24.92 ± 0.32 26.53 ± 0.76 0.028
aAn unpaired Student’s t-test was performed for the samples derived from the two approaches. Data represent mean ± SD for three biological replicates.
Figure 3. Purification and sequencing of BCG 5S rRNA and a proposed
model for 5S rRNA processing. (A) A Bioanalyzer electropherogram for
HPLC-purified 5S rRNA shows high purity. (B) Comparison of sequenced
5S rRNA against its annotated gene sequence. A total of six nucleotides
are absent from the sequenced 5S rRNA (highlighted in red). (C) Possible
fates of the putative 9S RNA, a precursor of functional 5S rRNA. Zeller
et al. demonstrated in vitro processing of 9S rRNA to a 116-nt 5S rRNAby
MycRNE/RNase E/G (44), while our analysis reveals different or further
in vivo processing to yield a 109-nt functional 5S rRNA molecule.
cleosides in RNA (15,26,27). As shown in Table 2, applica-
tion of this platform to BCG 5S rRNA revealed seven mod-
ified ribonucleosides: N1-methyladenosine (m1A), N6,N6-
dimethyladenosine (m6,6A), N7-methylguanosine (m7G),
N1-methylguaonsine (m1G), 2′-O-methylguanosine (Gm)
and inosine (I), each with distinct mass-to-charge transi-
tion ratios and retention times as shown in Supplementary
Figure S6. The structures of six of the modified ribonucle-
osides were confirmed with synthetic standards, while the
structure of the seventh is tentatively assigned asN4-methyl-
2′-O-methylcytidine (m4Cm) based on CID fragmentation
patterns.
DISCUSSION
While there are established approaches for isolating spe-
cific types of RNA from mycobacteria (19–22), there are
no methods that have been optimized to yield the complete
set of commonly recognized ncRNA species (tRNA and 5S,
16S and 23S rRNA). The value of preserving the fidelity of
a cellular RNA population by isolating the full complement
of ncRNA is illustrated in recent discoveries of many new
ncRNA species in M. tuberculosis based on genomic anal-
yses (13,14) and with the application of quantitative RNA-
seq methods to both coding and ncRNA in mycobacteria
(35). Furthermore, the systems-level analysis modified ri-
bonucleosides in mycobacterial ncRNA also requires iso-
lation of the full spectrum of ncRNA species (15–17). To
address these challenges, we usedM. bovis BCG to develop
an optimizedmethod for mycobacterial RNA isolation that
combines accessible reagents and approaches with commer-
cial kits to achieve rapid isolation of the full spectrum of
ncRNA in high yield with minimal artifacts. The method
yielded high-quality ncRNA and led to the discovery of
novel post-transcriptional processing of 5S rRNA in BCG.
A step-by-step analysis of the RNA isolation method
provides insights into the importance of preserving both the
quantitative and qualitative fidelity of the isolated RNA.
Perhaps the most challenging step in mycobacterial RNA
isolation involves cell lysis, owing to the unique biochem-
istry of mycobacterial cell walls, which renders them refrac-
tory to typical chaotropic or mild detergent-based cell ly-
sis solutions used with other bacteria and eukaryotic cells.
Several methods to overcome this problem have been devel-
oped, including enzymatic spheroplasting followed by son-
ication (19), detergent-based lysis (20), mechanical disrup-
tion by bead-beating (21) and mechanical shearing with a
French pressure cell (22). However, in the absence of de-
naturants, all of these methods provide an opportunity for
adventitious enzymatic reactions to occur during the lysis
step, including nuclease degradation and alteration of mod-
ified ribonucleosides in the RNA. Our approach of bead-
beating in the presence of a strong denaturant such as phe-
nol:chloroform:isoamyl alcohol minimizes artifacts by re-
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Table 2. List of modified bases detected in BCG 5S rRNA
Ribonucleoside Abbreviation Formula
Precursor
(m/z)
Product
(m/z)
Transition
(m/z)
Retention
time (min)
Adenosine A C10H13N5O4 268.1 136.1 132 5.09
Uracil U C4H4N2O2 245.1 113.1 132 2.45
Guanosine G C10H13N5O5 284.0 152.0 132 6.44
Cytidine C C4H5N3O 244.1 112.1 132 1.65
Inosine I C10O5N4H12 269.1 137.1 132 5.38
1-Methyl-adenosine m1A C11O4N5H15 282.1 150.1 132 2.53
N6,N6-Dimethyl-adenosine m6,6A C12O4N5H17 296.1 164.1 132 20.49
7-Methyl-guanosine m7G C11O5N5H17 298.1 166.1 132 4.69
1-Methyl-guanosine m1G C11O5N5H15 298.1 166.1 132 13.72
2′-O-Methyl-guanosine Gm C11O5N5H15 298.1 152.1 146 14.54
N4, 2′-O-Dimethyl-cytidinea m4Cm C11O5N3H17 272.1 112.1 160 22.64
aTentative identification based on exact molecular weight and collision-induced dissociation fragmentation pattern. The identities of the other modified
ribonucleosides were determined by comparisons to accurate mass measurements on an HPLC-coupled quadrupole time of flight mass spectrometer as
well as retention times of chemical standards on an HPLC-coupled triple quadrupole mass spectrometer operated in positive ion mode.
ducing the time required for lysis and by quenching all phys-
iological and biochemical processes.
It is also important to consider the choice of denaturing
extraction solvents as a determinant the fidelity of the RNA
population. The introduction of the ‘single-step’ method of
RNA isolation using acid guanidinium thiocyanate-phenol-
chloroform (i.e. TRIzol) provided versatility and ease in re-
trieving RNA from a wide variety of sources (36). How-
ever, Kim et al. recently described poor recovery of small
RNA with low GC content when utilizing the isopropanol
precipitation step in the TRIzol approach, challenging the
assumption that total RNA preparations recover all RNA
species with equal efficiency (23). We also observed that
TRIzol yields a smaller proportion of 16S and 23S rRNA
from mycobacteria compared to the phenol, chloroform,
isoamyl alcohol mixture (Supplementary Figures S2B and
S4). The alternative use of cetyltrimethylammonium bro-
mide with phenol and bead-beating for RNA extraction
from mycobacteria by Cheung et al. (37) proved to be
problematic (20). For retrieval of RNA from the extrac-
tion solvents, an isopropanol precipitation step is frequently
used, though this results in biases against small RNAs.
Given these issues of extraction and recovery, we found that
the combination of phenol:chloroform:isoamyl alcohol ex-
traction with bead-beating followed by solid-phase extrac-
tion columns for RNA retrieval provided optimal RNA
yields in terms of quantity and quality. As the use of phe-
nol:chloroform:isoamyl alcohol at an alkaline pH increases
the co-purification of genomic DNA, a DNA removal step,
such as addition of DNase I or HPLC purification, should
be employed for downstream applications involving PCR
amplification or chemical analysis of RNA. The solid phase
extraction technology is based on nucleic acid binding to
silica-based polymers with RNA retention dependent on
the concentration of salt and ethanol in the aqueous phase
(38). Lower percentages of ethanol (e.g. 35%) allow reten-
tion of larger RNA while higher percentages of ethanol
(e.g. 70%) retain small RNA. While there is significant
loss of small RNAs, most notably tRNA, on the column
supposedly retaining large RNAs (column #1 in the cur-
rent method), quantitative recovery of all RNA species is
achieved by combining the eluates from both columns.
This optimized approach of using denaturing extraction
solvents during bead-beating to lyse mycobacteria followed
by solid-phase recovery of RNA allows for rapid, efficient
isolation of the complete set of ncRNA species with min-
imal degradation artifacts. The efficiency of the method is
evident in the yield of DNA-free RNA, which amounted to
a reproducible 2.6 g of RNA from 109 bacilli (i.e. 2.6 fg
per cell). This amount of cellular RNA is consistent with
recent studies on the molecular composition of mycobacte-
ria that gave a theoretical total content of RNA in a single
BCG bacillus at 2.2–10 fg with dependence on the growth
rate (29). Given our isolation results and the agreement with
theoretical RNA amounts, previous claims of 20 fg RNA
per cell for mycobacteria are likely over-estimates possibly
resulting from DNA or other contamination (20,37). For
the highest degree of purity needed for chemical analysis
of RNA, for example, individual RNA species can be puri-
fied by one-, two- or even three-dimensional chromatogra-
phy combining size-exclusion with reversed-phase matrices
(26). This step provides an opportunity to remove contam-
inating DNA and DNase I. In our experiments, we show
essentially complete digestion of DNA by DNase I in or-
der to minimize DNA contamination in purification steps
(Supplementary Figure S5).
The immediate application of this method to the M. tu-
berculosis surrogate, M. bovis BCG, which is also the tu-
berculosis vaccine strain, led to three important observa-
tions: pathophysiological shifts in the relative quantities of
ncRNA species, and novel post-transcriptional processing
of the elusive 5S rRNA in terms of sequence trimming and
an expanded set of modified ribonucleosides. Among a va-
riety of environmental changes that occur in the hallmark
pathology ofM. tuberculosis infection, oxygen depletion in
vitro and granulomas have been shown to induce a non-
replicative persistent state that mimics the dormant state of
tuberculosis bacilli (39); this phenotype is shared by BCG
and the faster growingM. smegmatis (40). Consistent with
the observation of a hypoxia-induced decrease in nucleic
acid synthesis (41) and loss of both 50S and 30S ribosomal
subunits (40), we observed significant decreases in the rel-
ative quantities of 16S and 23S at the fully developed non-
replicative state at 21 days of hypoxia (Figure 2C). Surpris-
ingly, the levels of small RNAs did not change significantly
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in the hypoxic state, either in terms of Bioanalyzer RNA
profiles or HPLC quantification. Furthermore, the decrease
in the relative quantity of 16S rRNA raises questions about
the feasibility of using bacterial 16S rRNA, a housekeeping
gene in bacterial gene expression studies, particularly those
examining stress conditions. While possible, it is unlikely
that the thicker cell wall of the hypoxic, non-replicative state
could lead to less cell wall disruption during the cell lysis
step and cause differential release of small and large ncRNA
species.
The optimized RNA isolation method also yielded in-
sights into the maturation and processing of 5S rRNA in
mycobacteria. In 1978, using temperature-sensitive rne Es-
cherichia coli mutants, several small RNA molecules were
discovered, including 9S RNA that contained the 5S rRNA
sequence (42). Further studies demonstrated that process-
ing of 9S RNA by RNase E and/or RNase G yields what
was thought to be a mature 5S rRNA (42,43). An RNase
E/G homolog was identified fromM. tuberculosis and was
characterized as a 5′-endoribonuclease able to cleave puta-
tive 9S RNA in vitro as well as in vivo (44). This RNase
E/G homolog, termed MycRne, was shown to cleave 9S
RNA in proximity to, but upstream of, the annotated ge-
nomic 5S rRNA sequence, with the difference attributed
to the association of ribosomal proteins. Using the RNA
isolation method with HPLC purification, we were able to
obtain a homogeneous population of 5S rRNA molecules
for sequence analysis and chemical analysis of modified ri-
bonucleosides. Sequencing of purified 5S rRNA uncovered
two sites of truncation with respect to the BCG 5S rRNA
gene, as shown in Figure 3B. Our findings strongly support
the idea of a cleavage downstream from, but in proximity
to, the start of the annotated genomic sequence, as well as
a cleavage one nucleotide upstream from the end sequence
to yield a functional 5S rRNA. To determine the cleavage
site of 9S RNA, the previously mentioned group incubated
PCR-amplified putative 9S sequences with a truncated form
of MycRne protein that was overexpressed in E. coli. Addi-
tionally, their group utilized primer extension of total RNA
to determine the position of the 5′ end of 5S rRNA. As
the sequences differed by one or two nucleotides, they at-
tributed the differences to the presence of ribosomal pro-
teins (44). The uniformity of the observed 5S rRNA se-
quence in our studies rigorously establishes the functional
form of this RNA.
In addition to sequence alterations, ncRNAs undergo
maturation in the form of post-transcriptional insertion
of dozens of different modified ribonucleosides, especially
tRNA. To date, however, there have been very few obser-
vations of modified ribonucleosides in 5S rRNA in either
eukaryotes or prokaryotes. Modified ribonucleosides in 5S
rRNA have been described in archaea and to a smaller ex-
tent, eukaryotes (45,46). Although Yan et al. claim to have
detected Am, Cm, m3C, m6A in mouse liver 5S rRNA, and
while Cm, ac4C, ac4Cm have been detected in Sulfolobus
solfataricus, Pyrodictium occultum and Haloferax volcanii
5S rRNA (46,47), the Albany Modification Database lists
only four modifications in 5S rRNA: Cm, ac4C, ac4Cm and
Y (48). Our analysis of BCG 5S rRNA thus adds seven
moremodified ribonucleosides to the 5S rRNA roster:m1A,
m66A, m7G, m1G, Gm, I and a putative m4Cm (Table 2).
Given the importance of rRNA modifications in 16S and
23S rRNA in ribosome assembly and translational fidelity,
as well as in mechanisms of resistance to aminoglycoside,
macrolide and linezolid antibiotics (49–52), it is reasonable
to assume that 5S rRNA modifications have potential ef-
fects with respect to bacterial growth and survival.
Given that the use of phenol:chloroform:isoamyl alco-
hol at an alkaline pH partitions nucleic acids in the or-
ganic phase (including mRNA), we sought to determine
if our method was suitable for mRNA isolation or gene
expression studies. We thus probed for the presence of
sevenmRNA transcripts on samples derived fromourRNA
isolation approach and samples derived from the conven-
tional TRIzol RNA isolation approach. Analysis showed
that the optimized phenol:chloroform:isoamyl alcohol ap-
proach resulted in a similar yield of mRNAwhen compared
to TRIzol-based RNA isolation, while the RIN data attest
to the quality of the total RNA preparation. We therefore
believe that total RNA derived from our approach can be
used for gene expression studies.
The results presented here demonstrate the utility of a
mycobacterial RNA isolation method that maximally pre-
serves the quantitative and qualitative fidelity of ncRNA
species. While optimized for ncRNA, the method also pro-
vides high fidelity isolation of mRNA from mycobacteria.
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